SNDX Syndax Pharmaceuticals Inc
Nasdaq · SEC CIK 1395937 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.75M 8 sales by 3 insiders
- Filings on record
- 121 since 2021-08-20, latest 2026-07-09 16:54
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Metzger Michael A | CEO, Dir | — | $1.43M |
| Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| Goldan Keith A. | CFO | — | $137.0K |
| Rizo Aleksandra | Dir | — | — |
| Jarrett Jennifer | Dir | — | — |
| Huber Martin H. Jr. | Dir | — | — |
| Legault Pierre | Dir | — | — |
| Katkin Keith | Dir | — | — |
| Podlesak Dennis | Dir | — | — |
Transactions 158
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-04 | 2022-09-30+ | SNDX | Katkin Keith | Dir | M - OptEx | $8.11 | +4,101 | 32.6K | +14% | +$33.2K |
| DM | 2022-09-21 | 2022-09-19+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $23.11 | -174.0K | 17.8K | -91% | -$4.02M |
| DM | 2022-09-21 | 2022-09-19+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $10.90 | +174.0K | 132.2K | New | +$1.90M |
| DM | 2022-09-16 | 2022-09-14+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $7.90 | +279.4K | 84.6K | New | +$2.21M |
| DM | 2022-09-16 | 2022-09-14+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $23.64 | -279.4K | 17.8K | -94% | -$6.60M |
| DM | 2022-09-16 | 2022-09-15+ | SNDX | Podlesak Dennis | Dir | S - Sale+OE | $24.08 | -78.8K | 75.8K | -51% | -$1.90M |
| DM | 2022-09-16 | 2022-09-15+ | SNDX | Podlesak Dennis | Dir | M - OptEx | $6.32 | +78.8K | 81.2K | +3,330% | +$498.3K |
| D | 2022-08-26 | 2022-07-29 | SNDX | Ordentlich Peter | CSO | J - Other | $14.12 | +265 | 265 | New | +$3,742 |
| DM | 2022-08-26 | 2022-08-24 | SNDX | Ordentlich Peter | CSO | M - OptEx | $6.32 | +25.0K | 23.1K | New | +$158.1K |
| DM | 2022-08-26 | 2022-08-24 | SNDX | Ordentlich Peter | CSO | S - Sale+OE | $25.04 | -25.0K | 265 | -99% | -$626.0K |
| DM | 2022-08-09 | 2022-08-05 | SNDX | Legault Pierre | Dir | M - OptEx | $9.22 | +24.0K | 46.0K | +109% | +$221.3K |
| DM | 2022-08-09 | 2022-08-05 | SNDX | Legault Pierre | Dir | S - Sale+OE | $23.02 | -24.0K | 32.0K | -43% | -$552.5K |
| DM | 2022-07-27 | 2022-07-25 | SNDX | Metzger Michael A | CEO, Dir | S - Sale+OE | $21.06 | -31.6K | 17.7K | -64% | -$665.5K |
| DM | 2022-07-27 | 2022-07-25 | SNDX | Metzger Michael A | CEO, Dir | M - OptEx | $6.38 | +31.6K | 29.5K | New | +$201.6K |
| DM | 2022-07-08 | 2022-07-06+ | SNDX | Metzger Michael A | CEO, Dir | M - OptEx | $6.38 | +15.1K | 17.8K | +570% | +$96.4K |
| DM | 2022-07-08 | 2022-07-06+ | SNDX | Metzger Michael A | CEO, Dir | S - Sale+OE | $21.07 | -15.1K | 17.7K | -46% | -$318.3K |
| D | 2022-07-05 | 2022-07-01 | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $7.20 | +62.3K | 80.1K | +349% | +$448.5K |
| D | 2022-07-05 | 2022-07-01 | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $19.00 | -62.3K | 17.8K | -78% | -$1.18M |
| D | 2022-06-15 | 2022-06-13 | SNDX | Goldan Keith A. | CFO | A - Grant | $0.00 | +3,205 | 3,205 | New | $0 |
| DMA | 2022-04-13 | 2022-04-01+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $7.20 | +73.7K | 88.4K | +501% | +$530.4K |
| DM | 2022-04-05 | 2022-04-01+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | S - Sale+OE | $17.48 | -104.2K | 42.3K | -71% | -$1.82M |
| DM | 2022-04-05 | 2022-04-01+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $10.90 | +73.7K | 88.4K | +501% | +$803.0K |
| D | 2022-02-03 | 2022-02-01 | SNDX | Ordentlich Peter | CSO | S - Sale | $16.65 | -1,412 | 0 | -100% | -$23.5K |
| D | 2022-02-03 | 2022-01-31 | SNDX | Ordentlich Peter | CSO | J - Other | $12.39 | +1,412 | 1,412 | New | +$17.5K |
| 2022-02-03 | 2022-02-02 | SNDX | Legault Pierre | Dir | A - Grant | $0.00 | +16.0K | 32.0K | +100% | $0 | |
| 2022-02-03 | 2022-02-02 | SNDX | Meury William | Dir | A - Grant | $0.00 | +16.0K | 32.0K | +100% | $0 | |
| 2022-02-03 | 2022-02-02 | SNDX | Egros Fabrice | Dir | A - Grant | $0.00 | +16.0K | 32.0K | +100% | $0 | |
| 2022-02-03 | 2022-02-02 | SNDX | Katkin Keith | Dir | A - Grant | $0.00 | +16.0K | 32.0K | +100% | $0 | |
| 2022-02-03 | 2022-02-02 | SNDX | Huber Martin H. Jr. | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 | |
| D | 2022-02-03 | 2022-01-31 | SNDX | Nolte Alexander | CAO | J - Other | $12.39 | +968 | 968 | New | +$12.0K |
| D | 2022-02-03 | 2022-02-01 | SNDX | Nolte Alexander | CAO | S - Sale | $16.65 | -968 | 0 | -100% | -$16.1K |
| D | 2022-02-03 | 2022-01-31 | SNDX | Meyers Michael L. | SVP, Chief Medical Off | J - Other | $12.39 | +1,714 | 23.3K | +8% | +$21.2K |
| 2022-02-03 | 2022-02-02 | SNDX | Podlesak Dennis | Dir | A - Grant | $0.00 | +32.0K | 75.8K | +73% | $0 | |
| 2022-02-03 | 2022-02-02 | SNDX | Jarrett Jennifer | Dir | A - Grant | $0.00 | +16.0K | 32.0K | +100% | $0 | |
| D | 2022-01-03 | 2021-12-30 | SNDX | Meyers Michael L. | SVP, Chief Medical Off | M - OptEx | $8.77 | +5,900 | 21.6K | +38% | +$51.7K |
| DM | 2021-12-22 | 2021-12-20+ | SNDX | Legault Pierre | Dir | S - Sale+OE | $21.56 | -44.0K | 16.0K | -73% | -$948.4K |
| DM | 2021-12-22 | 2021-12-20+ | SNDX | Legault Pierre | Dir | M - OptEx | $7.52 | +44.0K | 40.0K | New | +$330.7K |
| D | 2021-12-20 | 2021-12-17 | SNDX | Morrison Briggs | CEO, Dir | S - Sale+OE | $20.00 | -35.2K | 48.3K | -42% | -$703.1K |
| D | 2021-12-20 | 2021-12-17 | SNDX | Morrison Briggs | CEO, Dir | M - OptEx | $10.90 | +35.2K | 83.5K | +73% | +$383.2K |
| DM | 2021-12-20 | 2021-12-16+ | SNDX | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.94 | -85.4K | 17.7K | -83% | -$1.70M |
| DM | 2021-12-20 | 2021-12-16+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.64 | +85.4K | 19.3K | New | +$652.3K |
| DM | 2021-12-15 | 2021-12-13 | SNDX | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.05 | -36.6K | 17.7K | -67% | -$697.4K |
| DM | 2021-12-15 | 2021-12-13 | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $6.43 | +36.6K | 19.7K | New | +$235.2K |
| DM | 2021-11-19 | 2021-11-18 | SNDX | Egros Fabrice | Dir | S - Sale+OE | $18.03 | -14.0K | 16.0K | -47% | -$253.0K |
| DM | 2021-11-19 | 2021-11-18 | SNDX | Egros Fabrice | Dir | M - OptEx | $8.93 | +14.0K | 30.0K | +88% | +$125.3K |
| DM | 2021-10-27 | 2021-10-25+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +61.0K | 34.0K | New | +$439.2K |
| DM | 2021-10-27 | 2021-10-25+ | SNDX | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.15 | -61.0K | 17.7K | -78% | -$1.17M |
| 2021-10-06 | 2021-10-05 | SNDX | Podlesak Dennis | Dir | J - Other | $0.00 | +463 | 43.8K | +1% | $0 | |
| D | 2021-09-28 | 2021-09-27 | SNDX | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.51 | -24.4K | 17.7K | -58% | -$476.8K |
| D | 2021-09-28 | 2021-09-27 | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +24.4K | 42.1K | +138% | +$175.9K |
| DM | 2021-09-22 | 2021-09-20+ | SNDX | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.23 | -36.6K | 17.7K | -67% | -$703.0K |
| DM | 2021-09-22 | 2021-09-20+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +36.6K | 18.0K | New | +$263.3K |
| DM | 2021-09-21 | 2021-09-17+ | SNDX | Morrison Briggs | CEO, Dir | S - Sale+OE | $20.07 | -70.3K | 48.3K | -59% | -$1.41M |
| DM | 2021-09-21 | 2021-09-17+ | SNDX | Morrison Briggs | CEO, Dir | M - OptEx | $7.20 | +70.3K | 118.6K | +146% | +$506.2K |
| DM | 2021-09-15 | 2021-09-13+ | SNDX | Metzger Michael A | Pres, COO, Dir | M - OptEx | $7.20 | +61.0K | 62.0K | +6,052% | +$439.2K |
| DM | 2021-09-15 | 2021-09-13+ | SNDX | Metzger Michael A | Pres, COO, Dir | S - Sale+OE | $19.11 | -61.0K | 17.7K | -78% | -$1.17M |
| D | 2021-08-20 | 2021-08-18 | SNDX | Egros Fabrice | Dir | S - Sale+OE | $15.75 | -15.6K | 16.0K | -49% | -$246.3K |
| D | 2021-08-20 | 2021-08-18 | SNDX | Egros Fabrice | Dir | M - OptEx | $7.88 | +15.6K | 31.6K | +98% | +$123.2K |
Purchase Sale Sale after option exercise All abbreviations